|Age:||-1 to 30 years old|
|Keywords:||Hepatic Malignancy, hepatocellular carcinoma, hepatoblastoma, pediatric cancer|
|Type:||Drug study, Phase [/2/,/ /3/]|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= 16 years: 1.7 (male), 1.4 (female)
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.